Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease ch
aracterized by selective motor neuronal death. The cause of ALS is unclear,
but accumulating evidence, such as the insufficient clearance of glutamate
through the glutamate transporter, and the specific distribution of Ca2+-p
ermeable AMPA receptors in spinal motor neurons, indicates that glutamate-i
nduced neurotoxicity is involved in its pathogenesis. Interestingly, nitric
oxide (NO), which has been identified as an endothelium-derived relaxing f
actor (EDRF), was found to be a pivotal inducer of glutamate-induced neuron
al death. NO is generated by nitric oxide synthase (NOS), of which there ar
e three subtypes: neuronal NOS expressed mainly in neurons, inducible NOS i
n astroglia, and endothelial NOS in vessels. NO-related toxicity is caused
by peroxynitrite, formed by the reaction of NO with superoxide anions, resu
lting in the nitration of tyrosine residues in neurofilaments, irreversible
inhibition of the mitochondrial respiratory chain, and inhibition of the g
lutamate transporter. Clinically, the axonal spheroids of motor neurons are
reported to be immunoreactive to anti-nitrotyrosine antibody, and there ar
e elevated levels of the metabolites of NO in the cerebrospinal fluid of AL
S patients. Since physiologically normal motor neurons express limited amou
nts of neuronal NOS, the source of NO is considered to be non-motor neurons
expressing neuronal NOS, astroglia expressing inducible NOS, or motor neur
ons themselves inducing neuronal NOS. Conversely, neurons containing neuron
al NOS are known to be resistant to toxic stimuli, which raises the possibi
lity that such neurons are protected by NO. Several mechanisms have been re
ported to mediate the NO-related neuroprotection, including cyclic guanosin
e 3',5'-monophosphate (cyclic GMP), a downstream product of NO generation.
This review summarizes previous studies on NO, focusing on its dual functio
ns of neurotoxicity or neu ro protection, and discusses the putative roles
of NO in relation to the pathogenesis of ALS.